Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Antagonizing NMDA

When one compound in a chemical class has problems, it's no big deal. When two do, eyebrows begin to rise. When three do, it may be time to rethink the target.

Further complicating the issue is the complexity of some of the indications targeted by NMDA antagonists. Cerestat and related compounds are intended to prevent neuronal injury by preventing glutamate-induced calcium influx into neurons. This influx is thought to occur primarily through the NMDA-receptor ion channel, leading to over-excitement and death of neurons.

The appeal of this targeting strategy is that activation of NMDA channels is thought to be essential in leading to neuronal death after stroke

Read the full 1058 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE